Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 38 - Medicinal preparations containing peptides
Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
03/1996
03/07/1996WO1996006629A1 HIGH-AFFINITY RESPONSE-SELECTIVE C-TERMINAL ANALOGS OF C5a ANAPHYLATOXIN
03/07/1996WO1996006628A1 Biologically active fragments of glucagon-like insulinotropic peptide
03/07/1996WO1996006627A1 Mutant enterotoxin effective as a non-toxic oral adjuvant
03/07/1996WO1996006626A1 Analgesic method with dynorphin analogues truncated at the n-terminus
03/07/1996WO1996006624A1 A mutant protein and methods and materials for making and using it
03/07/1996WO1996006621A1 Metal complex containing oligonucleoside cleavage compounds and therapies
03/07/1996WO1996006619A1 Polynucleic acids and proteins from a porcine reproductive and respiratory syndrome virus and uses thereof
03/07/1996WO1996006532A1 A basic protein composition for killing or inhibiting microbial cells
03/07/1996WO1996004385A3 Purified hepatitis c virus envelope proteins for diagnostic and therapeutic use
03/07/1996WO1996003515A3 Surface expression of enzyme in gene directed prodrug therapy
03/07/1996WO1996002641A3 Materials and methods relating to the diagnosis and prophylactic and therapeutic treatment of synovial sarcoma
03/07/1996WO1995032430A3 Assay for pathogenicity of anti-dna antibodies
03/07/1996WO1995032291A3 Hepatitis g virus and molecular cloning thereof
03/07/1996WO1995019777A3 Use of diesters of muramyl peptides in oral form as immunostimulating agents
03/07/1996DE4431297A1 Antibody VFF-18 specific for epitope encoded by exon v6 of CD44
03/07/1996DE19532001A1 New antibacterial peptide, moricin, from silkworms
03/07/1996DE19531931A1 Modulatoren des Körpergewichts, korrespondierende Nukleinsäuren und Proteine, und diagnostische und therapeutische Verwendungen derselben Modulators of body weight, corresponding nucleic acids and proteins, and diagnostic and therapeutic uses thereof
03/07/1996DE19500548A1 Compsn. for treating snoring
03/07/1996CA2199005A1 Compositions and methods for delivery of polypeptides
03/07/1996CA2198919A1 Gradual modification, super agonists and antagonists of signs and peptides
03/07/1996CA2198721A1 Pharmaceutical compositions containing a bile salt and a buffer for increased bioavailability of an active compound
03/07/1996CA2198587A1 Trophic factors for central nervous system regeneration
03/07/1996CA2198474A1 Genetic therapy of diseases of the central nervous system with a cell-specific active substance which is dependent on the cell cycle
03/07/1996CA2198473A1 Gene therapy of tumors with an endothelial cell-specific, cell cycle-dependent active compound
03/07/1996CA2198472A1 Genetic therapy of vascular diseases with a cell-specific active substance which is dependent on the cell cycle
03/07/1996CA2198462A1 Genetic therapy of diseases caused by the immune system, said therapy using a cell-specific active substance regulated by the cell cycle
03/07/1996CA2198362A1 Topical anti-inflammatory composition and method
03/07/1996CA2198348A1 Analgesic method with dynorphin analogues truncated at the n-terminus
03/07/1996CA2198345A1 Improvements in production of proteins in host cells
03/07/1996CA2198080A1 Cell cycle regulated repressor and dna element
03/07/1996CA2197566A1 New peptide derivatives with .delta. opioid receptor antagonist or mixed.mu. agonist/.delta. antagonist effects
03/07/1996CA2197427A1 Gene therapy for transplantation and inflammatory or thrombotic conditions
03/06/1996EP0699766A1 Therapeutic antibody based fusion proteins with platelet factor-4
03/06/1996EP0699764A1 A method of using eukaryotic expression vectors comprising the BK virus enhancer
03/06/1996EP0699756A1 Novel mutant BR96 antibodies and functional equivalents reactive with human carcinomas
03/06/1996EP0699755A2 Method for obtaining modified immunoglobulins with reduced immunogenicity of murine antibody variable domains, compositions containing them
03/06/1996EP0699754A1 Method for diagnosing a predisposition for breast and ovarian cancer
03/06/1996EP0699753A2 Protein for the transport of cationic xenobiotic and/or pharmaceutical compounds, DNA sequences coding therefore and its uses
03/06/1996EP0699752A2 Mutated recombinant collagens
03/06/1996EP0699751A1 Antisense complementary to HCV genome
03/06/1996EP0699686A2 Biologically active fragments of glucagon-like insulinotropic peptide
03/06/1996EP0699444A2 Composition for the treatment of intestinal wounds or ulcers containing proteins, carbohydrates and fat
03/06/1996EP0699238A1 Dna encoding two fish neuropeptides
03/06/1996EP0699236A1 Purified mammalian flt3 ligands and agonists and antagonists thereof
03/06/1996EP0699210A1 Topical fibrinogen complex
03/06/1996EP0699209A1 PROCESSES AND INTERMEDIATE COMPOUNDS USEFUL FOR THE PREPARATION OF PLATELET GLYCOPROTEIN IIb/IIIa INHIBITORS
03/06/1996EP0699208A1 Novel peptide nucleic acids
03/06/1996EP0699079A1 Bioactive and/or targeted dendrimer conjugates
03/06/1996EP0699078A1 A method to prevent side effects and insensitivity to the therapeutic uses of toxins
03/06/1996EP0699075A1 Modified factor vii
03/06/1996EP0699074A1 Thrombin inhibitors
03/06/1996EP0699073A1 Allogeneic and xenogeneic transplantation
03/06/1996EP0699071A1 Anti-viral guanosine-rich oligonucleotides
03/06/1996EP0615444B1 Peroral administration form for peptidic medicaments, in particular insulin
03/06/1996EP0528949B1 An apparatus for preparing a concentrate of coagulation factors, such as fibrinogen, from a blood sample
03/06/1996EP0479899B1 Vasodilatory and immune suppressant peptides
03/06/1996EP0476059B1 Methods for enhancing the rate of modification of metastable bonds
03/06/1996EP0395653B1 Synovial phospholipases
03/06/1996EP0387319B1 Secretory leader sequences
03/06/1996EP0362259B1 Method of producing cystatin c or modifications hereof and dna-sequence for use when carrying out the method
03/06/1996CN1118143A Excipient stabilization of polypeptides treated with organic solvents
03/06/1996CN1118142A Combinations of retroviral inhibitors
03/06/1996CN1118141A Combination of a soluble complement receptor -1(SCR1) and an amidinophenyl or amidinonaphthyl-ester for treating inflammation
03/06/1996CN1118139A Fibrinogen receptor antagonists
03/06/1996CN1118008A Erythropoietin for human
03/06/1996CN1117874A Nasally administrable compositions
03/06/1996CN1117873A Usage of follicle-stimulating hormone
03/06/1996CN1031205C Method for preparation of ginseng wine for recovering "yang"
03/06/1996CN1031193C Polypeptide and method for preparing same
03/06/1996CA2157531A1 Htfiiia gene
03/05/1996US5497228 Laser bevel meter
03/05/1996US5496938 Nucleic acid ligands to HIV-RT and HIV-1 rev
03/05/1996US5496934 Nucleic acids encoding a cellulose binding domain
03/05/1996US5496928 Endothelin antagonistic substance
03/05/1996US5496927 Peptidase inhibitors
03/05/1996US5496926 Process of preparing a soluble LDL receptor
03/05/1996US5496856 Aspartame for its application as a therapeutically active substance
03/05/1996US5496834 Peptide derivatives as cathepsin l inhibitors and inhibitors of bone resorption or treatment of osteoporosis
03/05/1996US5496810 Pyrimidine deoxyribonucleoside potentiation of combination therapy based on 5-fluorouracil and interferon
03/05/1996US5496805 Inhibitors of neutral endopeptidase
03/05/1996US5496804 Method for treating taxol side-effects with G-CSF
03/05/1996US5496803 Administering prolactin by itself or with a glucosteroid such as cortisol
03/05/1996US5496802 Protein; antibody
03/05/1996US5496801 Storage stability, mannitol, citric acid buffer
03/05/1996US5496800 Growth inhibitory factor from urogenital sinus
03/05/1996US5496731 Anti-oncogenes
03/05/1996US5496724 Genes encoding platelet aggregation inhibitors
03/05/1996US5496718 Chondroitinase ABC isolated from proteus vulgaris ATCC 6896
03/05/1996US5496712 High molecular weight collagen-like protein polymers
03/05/1996US5496706 Methods and materials for the detection of Staphylococcus aureus
03/05/1996US5496705 Monoclonal antibody specific for rat synaptophysin
03/05/1996US5496698 Method of isolating ribozyme targets
03/05/1996US5496554 Purified mite allergen
03/05/1996US5496552 Osteogenic devices
03/05/1996US5496551 Polypeptide immunogens
03/05/1996US5496549 Bispecific monoclonal antibodies, thrombolytic agent and method of cell lysis
03/05/1996US5496548 Human anti-RH(D) monoclonal antibodies, cell lines and methods of use of antibodies in immunoassays
03/05/1996CA1338122C Tissue factor inhibitor of coagulation
03/05/1996CA1338121C Anticonvulsant and neuroprotective 2-aminoacetamide derivatives
03/03/1996CA2131438A1 Method and composition for treating intestinal wounds or ulcers
1 ... 2800 2801 2802 2803 2804 2805 2806 2807 2808 2809 2810 2811 2812 2813 2814 2815 2816 2817 2818 2819 2820 ... 3163